Rocuronium bromide and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rocuronium bromide (rocuronium bromide) and Lantus (insulin glargine recombinant). Common drug interactions include renal failure among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Rocuronium bromide and Lantus. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Rocuronium bromide?

Rocuronium bromide has active ingredients of rocuronium bromide. eHealthMe is studying from 5,615 Rocuronium bromide users. Check the latest studies of Rocuronium bromide.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.



On Jul, 17, 2026

26 people who take Rocuronium bromide and Lantus together, and have interactions are studied.

Rocuronium bromide and Lantus drug interactions.

What are the common drug interactions of Rocuronium Bromide and Lantus, by gender? *:

female:

  1. Renal failure (kidney dysfunction)
  2. Renal injury (kidney injury)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Renal impairment (severely reduced kidney function)
  5. Stress
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Death
  8. Acute respiratory failure
  9. Anaemia (lack of blood)
  10. Blood pressure fluctuation

male:

  1. Anxiety
  2. Dyspepsia (indigestion)
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Blood magnesium decreased
  6. Blood sodium decreased
  7. Bone disorder
  8. Bone marrow disorder
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)

What are the common drug interactions of Rocuronium Bromide and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Dizziness
  3. Dry eye (lack of adequate tears)
  4. Duodenitis (inflammation of the duodenum)
  5. Dyspepsia (indigestion)
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Dysphonia (speech disorder attributable to a disorder of phonation)
  8. Dyspnoea (difficult or laboured respiration)
  9. Dysuria (painful or difficult urination)
  10. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)

50-59:

  1. Renal failure (kidney dysfunction)
  2. Renal injury (kidney injury)
  3. Anxiety
  4. Emotional distress
  5. Fear
  6. Multi-organ failure (multisystem organ failure)
  7. Pain
  8. Renal impairment (severely reduced kidney function)
  9. Stress
  10. Chronic kidney disease

60+:

  1. Anxiety
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Renal impairment (severely reduced kidney function)
  4. Renal injury (kidney injury)
  5. Stress
  6. Acute respiratory failure
  7. Anaemia (lack of blood)
  8. Blood pressure fluctuation
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Fungal infection

What are the existing conditions these people have? *

  1. Pain: 4 people, 15.38%
  2. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 15.38%
  3. Pharyngitis (inflammation of the pharynx, causing a sore throat): 3 people, 11.54%
  4. Endocarditis (inflammation in heart muscle): 3 people, 11.54%
  5. Constipation: 3 people, 11.54%
  6. Abscess (pus): 3 people, 11.54%
  7. Infection: 2 people, 7.69%
  8. High Blood Cholesterol: 2 people, 7.69%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.69%
  10. Blood Pressure Abnormal: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Rocuronium bromide and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rocuronium bromide and Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rocuronium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rocuronium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lantus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rocuronium bromide and insulin glargine recombinant (the active ingredients of Rocuronium bromide and Lantus, respectively), and Rocuronium bromide and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: